Ten‐year experience in optimizing neoadjuvant therapy for localized pancreatic cancer—Medical college of Wisconsin perspective
Erin Ward(Huntsman Cancer Institute), Susan Tsai(The Ohio State University Wexner Medical Center), Douglas B. Evans(The University of Texas MD Anderson Cancer Center)
Cited by 6
Related Papers
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Population-Based Study of Islet Cell Carcinoma
|Annals of Surgical Oncology|2007|338
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281